NAT10 and cancer: Looking ahead, utilizing these cutting‐edge technologies for developing drugs targeting NAT10 and its RNA ac4C modification may offer more precise and personalized treatment options for cancer therapy, greatly improving clinical outcomes and patient prognoses.